SCHEMBL6257741

SCHEMBL6257741

CC(I)OC(=O)Oc1ccccc1[N+](=O)[O-]

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.50
TDP1 Q9NUW8 1/20 0.50
L3MBTL1 Q9Y468 2/20 0.49
HTT P42858 1/20 0.47
MAPT P10636 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
RAB9A P51151 4/20 0.45
NPC1 O15118 2/20 0.45
RECQL P46063 1/20 0.45
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
KDM4E B2RXH2 1/20 0.43
POLB P06746 1/20 0.42
HPGD P15428 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
ESR2 Q92731 1/20 0.41
LMNA P02545 1/20 0.41
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8134133 0.88 ALDH1A1 (0.53) ALDH1A1TDP1L3MBTL1HTTMAPT
SCHEMBL5164726 0.85 ALDH1A1 (0.50) ALDH1A1TDP1L3MBTL1HTTMAPT
SCHEMBL983419 0.83 ALDH1A1 (0.62) ALDH1A1TDP1L3MBTL1HTTMAPT
SCHEMBL57736 0.82 ALDH1A1 (0.60) ALDH1A1TDP1L3MBTL1HTTMAPT
SCHEMBL29911025 0.82 ALDH1A1 (0.60) ALDH1A1TDP1L3MBTL1HTTMAPT
SCHEMBL6443734 0.81 ALDH1A1 (0.48) ALDH1A1TDP1L3MBTL1HTTMAPT
SCHEMBL6893509 0.80 KMT2A (0.49) ALDH1A1L3MBTL1HTTMAPTKMT2A
Bicarbonate SCHEMBL18955378 0.79 ALDH1A1 (0.56) ALDH1A1TDP1L3MBTL1HTTMAPT
Bicarbonate SCHEMBL18955379 0.79 ALDH1A1 (0.56) ALDH1A1TDP1L3MBTL1HTTMAPT
SCHEMBL7417979 0.79 POLB (0.46) ALDH1A1TDP1L3MBTL1HTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1575494-A2 ENGINEERING ABSORPTION OF THERAPEUTIC COMPOUNDS VIA COLONIC TRANSPORTERS Xenoport, Inc. (US) 2005-09-21 EP disclosed
WO-2003065982-A2 ENGINEERING ABSORPTION OF THERAPEUTIC COMPOUNDS VIA COLONIC TRANSPORTERS XENOPORT, INC. (US) 2003-08-14 WO disclosed